Skip to main content

Table 3 Intraoperative data of patients

From: Morbidity and mortality of nonagenarians undergoing CoreValve implantation

Parameter

Procedural success, n (%)

11 (100)

Conversion to surgical AVR, n (%)

0 (0)

Intraprocedural circulatory depression, n (%)

1 (9.1)

Catecholamine therapy, n (%)

1 (9.1)

Resuscitation, n (%)

1 (9.1)

Defibrillation, n (%)

1 (9.1)

Vascular access site complication requiring surgery, n (%)

1 (9.1)

Contrast agent (ml)

120.9 ± 44.7

Procedure time (min)

110.3 ± 29.5

Fluoroscopy time (min)

16.0 ± 6.8

CoreValve size (mm)

 

 26

9 (81.8)

 29

2 (18.2)

Pre TAVI valvuloplasty, n (%)

11 (100)

Post TAVI valvuloplasty, n (%)

5 (45.5)

Number of inflations after TAVI (n)

1.2 ± 0.6

Balloon diameter (mm)

20.6 ± 1.8

Balloon length (mm)

62.7 ± 16.8

Valve embolization, n (%)

2 (18.2)

Post TAVI aortic valve mean gradient

5.3 ± 4.1

Angiographic aortic insufficiency (grade)

0.9 ± 0.45

ICU stay (days)

3.36 ± 1.9

Hospital stay (days)

18.5 ± 5.4